Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)

Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)

US Patent 9920134 · Granted Mar 20, 2018

Estimated economic value: $108,797,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody therapies for human immunodeficiency virus (HIV)2025
Real time key conversational metrics prediction and notability2025
Anti-HIV antibody 10-1074 variants2025
Antibodies to TIGIT2025
Polynucleotides encoding human beta klotho antibodies or binding fragments there2025
Anti-ASGR-1 monoclonal inhibitory antibodies2025
MAGEB2 binding constructs2025
Facilities and processes to produce biotherapeutics2025
Binding proteins and methods of use thereof2024
Compositions and methods of use for treating metabolic disorders2024
Anti-CD33 antibodies and uses thereof2024
Implementing a generative machine learning architecture to produce training data2024